CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma - PubMed (original) (raw)
CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma
Akihiko Sano et al. Ann Surg Oncol. 2009 Feb.
Abstract
Esophageal cancer is one of the most difficult malignancies to cure, and identification of novel prognostic markers for patients with this disease is important. CD24 is a small highly glycosylated mucin-like protein. Several studies have shown that higher CD24 expression is significantly associated with shorter patient survival in various malignant tumors. However, the expression of CD24 and its clinicopathological significance in esophageal cancer remain largely unknown. Immunohistochemical analyses of CD24 and Ki-67 overexpression in 151 cases of esophageal squamous cell carcinoma were performed to examine the relationships of CD24 expression with clinicopathological parameters and patient survival. Five cell lines derived from esophageal cancer were subjected to Western blot analyses to evaluate CD24 expression. Immunohistochemically, CD24 expression was judged to be positive in 61 (40.4%) cases. CD24 expression was associated with lymph node metastasis (p = 0.005), pathologic stage (p = 0.018), number of nodal metastases (p = 0.003), lymphatic invasion (p = 0.002), venous invasion (p < 0.001), and Ki-67 labeling index (p < 0.001). The Pearson's correlation coefficient between the CD24 expression score and the Ki-67 labeling index was 0.404 (p < 0.001). CD24 expression was associated with disease-free survival (p < 0.001). A Cox multivariate regression analysis revealed that CD24 expression was an independent prognostic factor (p = 0.033). On Western blot analysis, CD24 was detected in all five cell lines. We conclude that overexpression of CD24, which was correlated with Ki-67 expression, is a novel independent prognostic marker for identifying patients with poor prognosis after curative resection of esophageal squamous cell carcinoma.
Similar articles
- Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Wang KL, et al. Cancer. 2007 Feb 15;109(4):658-67. doi: 10.1002/cncr.22445. Cancer. 2007. PMID: 17211865 - Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H. Sakai M, et al. Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5. Epub 2009 Jun 13. Ann Surg Oncol. 2009. PMID: 19526206 - Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H. Kato H, et al. J Surg Oncol. 2005 May 1;90(2):89-94. doi: 10.1002/jso.20249. J Surg Oncol. 2005. PMID: 15844180 - Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
Poincloux L, Durando X, Seitz JF, Thivat E, Bardou VJ, Giovannini MH, Parriaux D, Barriere N, Giovannini M, Delpero JR, Monges G. Poincloux L, et al. Surg Oncol. 2009 Dec;18(4):357-65. doi: 10.1016/j.suronc.2008.09.003. Epub 2008 Nov 21. Surg Oncol. 2009. PMID: 19027288 Review. - Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma.
Tachibana M, Kinugasa S, Hirahara N, Yoshimura H. Tachibana M, et al. Eur J Cardiothorac Surg. 2008 Aug;34(2):427-31. doi: 10.1016/j.ejcts.2008.04.022. Epub 2008 May 23. Eur J Cardiothorac Surg. 2008. PMID: 18502142 Review.
Cited by
- Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.
Moon SY, Han M, Ryu G, Shin SA, Lee JH, Lee CS. Moon SY, et al. Int J Mol Sci. 2023 Oct 11;24(20):15072. doi: 10.3390/ijms242015072. Int J Mol Sci. 2023. PMID: 37894750 Free PMC article. Review. - Soluble CD24 is an inflammatory biomarker in early and seronegative rheumatoid arthritis.
Zheng X, Wang P, Song J, Tang Y, Xie Y, Jin X, Zhu D, Fang X, Wei C, Li R, Hu F, Li Z. Zheng X, et al. Ann Med. 2023;55(2):2246370. doi: 10.1080/07853890.2023.2246370. Ann Med. 2023. PMID: 37591778 Free PMC article. - The prognostic value of separate lymphatic invasion and vascular invasion in oesophageal squamous cell carcinoma: a meta-analysis and systematic review.
Wang A, Tan Y, Wang S, Chen X. Wang A, et al. BMC Cancer. 2022 Dec 19;22(1):1329. doi: 10.1186/s12885-022-10441-6. BMC Cancer. 2022. PMID: 36536299 Free PMC article. - Expression and Prognostic Significance of Metastasis-Associated Protein 1 in Gastrointestinal Cancer.
Li P, Cao W, Ding R, Cheng M, Xu X, Chen S, Chen B, Cao G, Xiong M. Li P, et al. Front Oncol. 2020 Dec 21;10:542330. doi: 10.3389/fonc.2020.542330. eCollection 2020. Front Oncol. 2020. PMID: 33409150 Free PMC article. - Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma.
Karnan S, Ota A, Murakami H, Rahman ML, Hasan MN, Wahiduzzaman M, Hanamura I, Quang Vu L, Inoko A, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y. Karnan S, et al. Cell Death Discov. 2020 Nov 18;6(1):127. doi: 10.1038/s41420-020-00364-1. Cell Death Discov. 2020. PMID: 33298865 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous